Weighted Average Number of Shares Outstanding, Basic of Enlivex Therapeutics Ltd. from 30 Jun 2021 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enlivex Therapeutics Ltd. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2025 was 23,855,663, a 22% increase year-over-year.
  • Enlivex Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 20,513,992, a 10% increase from 2023.
  • Enlivex Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 18,574,484, a 0.98% increase from 2022.
  • Enlivex Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 18,394,886, a 3% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Enlivex Therapeutics Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 23,855,663 +4,310,607 +22% 01 Apr 2025 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q2 2024 19,545,056 +960,255 +5.2% 01 Apr 2024 30 Jun 2024 6-K 29 Aug 2025 2025 Q2
Q2 2023 18,584,801 +209,595 +1.1% 01 Apr 2023 30 Jun 2023 6-K 30 Aug 2024 2024 Q2
Q2 2022 18,375,206 +69,324 +0.38% 01 Apr 2022 30 Jun 2022 6-K 01 Sep 2023 2023 Q2
Q2 2021 18,305,882 01 Apr 2021 30 Jun 2021 6-K 22 Aug 2022 2022 Q2

Enlivex Therapeutics Ltd. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 20,513,992 +1,939,508 +10% 01 Jan 2024 31 Dec 2024 20-F 30 Apr 2025 2024 FY
2023 18,574,484 +179,598 +0.98% 01 Jan 2023 31 Dec 2023 20-F 30 Apr 2025 2024 FY
2022 18,394,886 +535,173 +3% 01 Jan 2022 31 Dec 2022 20-F 30 Apr 2025 2024 FY
2021 17,859,713 01 Jan 2021 31 Dec 2021 20-F 30 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.